Should NSAIDs Be Stopped for Chronic Hemorrhoids?
Yes, NSAIDs should be discontinued in patients with chronic hemorrhoids, particularly if there is any active bleeding, due to their antiplatelet effects that can exacerbate hemorrhoidal bleeding and increase gastrointestinal bleeding risk.
Clinical Reasoning
The most recent and relevant guideline evidence comes from the 2021 WSES-AAST Anorectal Emergencies Guidelines, which explicitly states: "No recommendation can be made regarding the role of NSAIDs, topical steroids, other topical agents, or injection of local anesthetics for complicated hemorrhoids, based on the available literature" 1. This absence of evidence supporting NSAID use, combined with their well-established bleeding risks, argues strongly for discontinuation.
Key Evidence Supporting Discontinuation
Bleeding Risk Profile
NSAIDs impair platelet function through cyclooxygenase inhibition, which directly increases bleeding risk 2. While the cystic fibrosis pulmonary guidelines address a different condition, they provide clear guidance applicable to any bleeding scenario: patients with at least mild (>5 ml) bleeding should stop NSAIDs 3. This principle translates directly to hemorrhoidal bleeding.
The 2026 meta-analysis demonstrates substantial variation in GI bleeding risk among NSAIDs, with ketorolac showing the highest risk (OR 20.67) and celecoxib the lowest (OR 1.16), though even ibuprofen carries significant risk (OR 2.28) 4. Hemorrhoids represent a pre-existing source of gastrointestinal bleeding that NSAIDs can worsen.
Lack of Therapeutic Benefit
The 2021 guidelines recommend dietary and lifestyle changes as first-line therapy (strong recommendation, 1B evidence) and flavonoids for symptom relief (weak recommendation, 2B evidence) 1. NSAIDs are conspicuously absent from recommended treatments, suggesting no established benefit that would justify their bleeding risk.
Clinical Algorithm for Decision-Making
Step 1: Assess for active bleeding
- Any visible blood with bowel movements → Stop NSAIDs immediately
- History of hemorrhoidal bleeding → Stop NSAIDs
Step 2: Evaluate bleeding risk factors
- Age ≥65 years
- Concurrent anticoagulant or antiplatelet therapy (increases bleeding risk 1.44-3.59 fold) 5
- History of GI bleeding
- Coagulation disorders
If any present → Stop NSAIDs
Step 3: Consider NSAID indication
- For pain control → Switch to acetaminophen (though monitor blood pressure) 6
- For inflammation → Consider topical muscle relaxants (nifedipine 0.3% + lidocaine 1.5%) which show 92% resolution rates for thrombosed hemorrhoids 1
Important Caveats
When NSAIDs Might Be Reconsidered
The cystic fibrosis guidelines note that NSAIDs "could be reinstituted once the bleeding has stopped" 3. However, for chronic hemorrhoids, this creates a problematic cycle since hemorrhoids are prone to recurrent bleeding. The safer approach is permanent discontinuation while hemorrhoids remain symptomatic.
Alternative Pain Management
- Acetaminophen: First-line alternative, though be aware it may increase blood pressure 6
- Topical agents: Nifedipine/lidocaine combinations for thrombosed hemorrhoids 1
- Flavonoids: Moderate evidence for symptom relief 1
- Fiber supplementation: Strong evidence as first-line therapy 1
Special Populations
For patients on anticoagulants or antiplatelets, NSAID use dramatically increases bleeding risk (OR 2.72-3.59 for GI bleeding) 5. These patients should absolutely avoid NSAIDs with hemorrhoids.
Common Pitfalls to Avoid
Don't assume OTC NSAIDs are safe: Patients often self-medicate with OTC NSAIDs and don't report this to physicians 7. Explicitly ask about ibuprofen, naproxen, and aspirin use.
Don't overlook aspirin: Even low-dose aspirin for cardiovascular prophylaxis increases bleeding risk. Weigh cardiovascular benefits against hemorrhoidal bleeding risk individually.
Don't prescribe NSAIDs for postoperative hemorrhoid pain without gastroprotection: If NSAIDs are deemed necessary post-hemorrhoidectomy 8, this represents a time-limited indication in a controlled setting, not chronic use.
Don't forget to assess coagulation: Check hemoglobin, hematocrit, and coagulation parameters to evaluate bleeding severity 1.
Bottom Line
Discontinue NSAIDs in patients with chronic hemorrhoids. The combination of established bleeding risk, lack of evidence supporting therapeutic benefit for hemorrhoids, and availability of safer alternatives makes this the prudent clinical decision. The 2021 guidelines' inability to recommend NSAIDs despite extensive literature review speaks volumes about their risk-benefit profile in this population 1.